Patents Assigned to InSight Biopharmacenticals Ltd.
  • Heparanase activity neutralizing anti-heparanase monoclonal antibody
    Patent number: 6946131
    Abstract: A method of treating a condition associated with heparanase expression by administering a heparanase activity neutralizing monoclonal anti-heparanase antibody, the monoclonal anti-heparanase antibody being for neutralizing heparanase catalytic activity.
    Type: Grant
    Filed: February 19, 2003
    Date of Patent: September 20, 2005
    Assignees: InSight Biopharmacenticals Ltd., Hadasit Medical Research Services and Development Ltd.
    Inventors: Tuvia Peretz, Daphna Miron, Yinon Shlomi, Iris Pecker, Maty Ayal-Hershkovitz, Israel Vlodavsky, Yael Friedmann